Venetoclax and Homoharringtonine‐Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T‐Cell Precursor Acute Lymphoblastic Leukemia

Documenti analoghi

• Homoharringtonine in Relapsed/Refractory Paediatric T‐Cell Acute Lymphoblastic Leukaemia—A Case Series and a Report on the Use of In Vitro Drug Profiling
  di: Pui Yung Grace Tong, et al.
  Pubblicazione: (2025)
• Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
  di: Andrew E. Place, et al.
  Pubblicazione: (2025)
• Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia
  di: Qingyang Liu, et al.
  Pubblicazione: (2025)
• Venetoclax Plus Daratumumab Bridging Allo‐HSCT in Early T‐Cell Precursor Acute Lymphoblastic Leukemia
  di: Fanqiao Meng, et al.
  Pubblicazione: (2025)
• Durable MRD‐Negative Remission With Blinatumomab and Venetoclax in Heavily Pretreated Relapsed/Refractory Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia
  di: Mohammad Shahzaib Qadir, et al.
  Pubblicazione: (2026)